Five years of telemonitoring in cystic fibrosis patients

S. Bella, F. Murgia, R. Colabianchi, V. Rebella, V. Lucidi (Rome, Italy)

Source: Annual Congress 2006 - Airway regulation, provocation and monitoring – II
Session: Airway regulation, provocation and monitoring – II
Session type: Thematic Poster Session
Number: 1312
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Bella, F. Murgia, R. Colabianchi, V. Rebella, V. Lucidi (Rome, Italy). Five years of telemonitoring in cystic fibrosis patients. Eur Respir J 2006; 28: Suppl. 50, 1312

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
NIV for children with cystic fibrosis
Source: ERS Course 2017 - Paediatric noninvasive ventilation
Year: 2017

The diagnosis of cystic fibrosis in adult COPD patients. A survey of 54 patients
Source: Eur Respir J 2001; 18: Suppl. 33, 215s
Year: 2001

A new paradigm for the management of children with cystic fibrosis at home: experiences from a Dutch cystic fibrosis clinic
Source: Virtual Congress 2021 – New technologies for the management of children with respiratory diseases
Year: 2021


The study of expectant life of St-Petersburg patients with cystic fibrosis (CF)
Source: Eur Respir J 2004; 24: Suppl. 48, 617s
Year: 2004

Non cystic fibrosis bronchiectasis in a pediatric clinic – 5 year evaluation
Source: Eur Respir J 2006; 28: Suppl. 50, 490s
Year: 2006

Exercise capacity in patients with cystic fibrosis vs non-cystic fibrosis bronchiectasis
Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases
Year: 2018

Ergospirometry in children with cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 229s
Year: 2003

Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis
Source: ERJ Open Res, 4 (1) 00111-2017; 10.1183/23120541.00111-2017
Year: 2018



The experience of patients with cystic fibrosis during pulmonary exacerbations: a mixed-method study
Source: International Congress 2017 – Nursing practice across respiratory care pathways
Year: 2017

The treatment burden of cystic fibrosis: a day-to-day experience with treatment as someone with cystic fibrosis
Source: Breathe, 17 (1) 210013; 10.1183/20734735.0013-2021
Year: 2021



Non-cystic fibrosis bronchiectasis: series of 89 patients
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008


Pneumothorax in paediatric cystic fibrosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 620s
Year: 2005

Comorbidities of advanced diseases in patients with cystic fibrosis
Source: Virtual Congress 2020 – Cystic fibrosis: from cradle to old age
Year: 2020


Pulmonary hypertension in cystic fibrosis patients
Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools
Year: 2008


Lumacaftor/ivacaftor-associated health stabilisation in adults with severe cystic fibrosis
Source: ERJ Open Res, 7 (1) 00203-2020; 10.1183/23120541.00203-2020
Year: 2021



Efficacy of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease
Source: Eur Respir J, 57 (2) 2003079; 10.1183/13993003.03079-2020
Year: 2021



Compliance with treatment in UK children with cystic fibrosis
Source: Eur Respir J 2001; 18: Suppl. 33, 538s
Year: 2001

Exercise training in patients with cystic fibrosis
Source: ERS Course 2020 - Pulmonary rehabilitation
Year: 2020